<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04113356</url>
  </required_header>
  <id_info>
    <org_study_id>AN3775</org_study_id>
    <nct_id>NCT04113356</nct_id>
  </id_info>
  <brief_title>Magnetic Resonance Imaging In Acute ST-Elevation Myocardial Infarction</brief_title>
  <acronym>MARINA-STEMI</acronym>
  <official_title>Clinical Relevance of Magnetic Resonance Imaging in Acute ST-Elevation Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University Innsbruck</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiovascular magnetic resonance imaging enables comprehensive assessment of cardiovascular
      function, morphology and pathology. The investigators aim to evaluate the nature and clinical
      significance of magnetic resonance imaging parameters in patients presenting with first acute
      ST-elevation myocardial infarction.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2011</start_date>
  <completion_date type="Anticipated">June 2031</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Occurence of major adverse cardiovascular events</measure>
    <time_frame>1 - 5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infarct size assessment (% of left ventricular myocardial mass)</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of infarct transmurality grade (%) with late gadolinium enhancement imaging</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurence and area of microvascular obstruction</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intramyocardial haemorrhage assessed by T2* imaging</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue characterisation by T1, T2 and T2* Mapping</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial deformation by strain analysis</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chamber volumes by cine imaging</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac function by cine imaging</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke volumes by phase contrast imaging</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic pulse wave velocity and distensibility by phase contrast imaging</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic pulse wave distensibility by phase contrast imaging</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life and invalidity assessment (Global Physical Activity Questionnaire)</measure>
    <time_frame>1 - 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarker release during the acute and subacute phase</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
    <description>neurohumoral markers (i.e. neprilysin ng/ml), inflammatory markers (i.e. procalcitonin Âµg/l) and markers of myocardial injury (i.e. high sensitivity cardiac troponin T ng/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parameters of cardiac function by transthoracic echocardiography</measure>
    <time_frame>baseline, 4 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque volume by 3D ultrasound</measure>
    <time_frame>baseline, 12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Acute ST-Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>ST-Elevation Myocardial Infarction</arm_group_label>
    <description>Patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiovascular Magnetic Resonance Imaging</intervention_name>
    <description>Cardiovascular magnetic resonance imaging will be performed within the first week after ST-elevation myocardial infarction and in a defined subgroup 4 months, 12 months and 10 years thereafter.</description>
    <arm_group_label>ST-Elevation Myocardial Infarction</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute ST-elevation myocardial infarction treated with primary percutaneous
        coronary intervention admitted to the coronary care unit of Innsbruck University Hospital
        for Internal Medicine III (Cardiology and Angiology).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  First ST-elevation myocardial infarction according to the European Society of
             Cardiology/American College of Cardiology committee criteria

          -  Primary percutaneous coronary intervention within 24 hours after symptom onset

        Exclusion criteria:

          -  Age &lt; 18 years

          -  Any history of a previous myocardial infarction or coronary intervention

          -  Clinically unstable patients (Killip class &gt;2)

          -  Renal failure (estimated glomerular filtration rate &lt; 30 ml/min/1.73 m2)

          -  Contraindications to cardiac magnetic resonance imaging (pacemaker, cerebral aneurysm
             clip, orbital foreign body, known or suggested contrast allergy to gadolinium,
             claustrophobia)

          -  Inability to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernhard Metzler, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital for Internal Medicine III (Cardiology and Angiology)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bernhard Metzler, MD, MSc</last_name>
    <email>bernhard.metzler@tirol-kliniken.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gert Klug, MD</last_name>
    <email>gert.klug@tirol-kliniken.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital for Internal Medicine III (Cardiology and Angiology)</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Metzler, MD, MSc</last_name>
      <email>bernhard.metzler@tirol-kliniken.at</email>
    </contact>
    <investigator>
      <last_name>Gert Klug, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sebastian Johannes Reinstadler, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Reindl, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christina Tiller, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Magdalena Holzknecht, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital for Radiology</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnes Mayr, MD</last_name>
      <email>a.mayr@i-med.ac.at</email>
    </contact>
    <investigator>
      <last_name>Agnes Mayr, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mathias Pamminger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 23, 2019</study_first_submitted>
  <study_first_submitted_qc>October 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 2, 2019</study_first_posted>
  <last_update_submitted>October 1, 2019</last_update_submitted>
  <last_update_submitted_qc>October 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

